Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression

Cell
Chih-Hao ChangErika L Pearce

Abstract

Failure of T cells to protect against cancer is thought to result from lack of antigen recognition, chronic activation, and/or suppression by other cells. Using a mouse sarcoma model, we show that glucose consumption by tumors metabolically restricts T cells, leading to their dampened mTOR activity, glycolytic capacity, and IFN-γ production, thereby allowing tumor progression. We show that enhancing glycolysis in an antigenic "regressor" tumor is sufficient to override the protective ability of T cells to control tumor growth. We also show that checkpoint blockade antibodies against CTLA-4, PD-1, and PD-L1, which are used clinically, restore glucose in tumor microenvironment, permitting T cell glycolysis and IFN-γ production. Furthermore, we found that blocking PD-L1 directly on tumors dampens glycolysis by inhibiting mTOR activity and decreasing expression of glycolysis enzymes, reflecting a role for PD-L1 in tumor glucose utilization. Our results establish that tumor-imposed metabolic restrictions can mediate T cell hyporesponsiveness during cancer.

References

Nov 1, 1995·The Journal of Experimental Medicine·S ConstantK Bottomly
May 4, 1999·The Journal of Experimental Medicine·D H MunnA L Mellor
Jul 18, 2002·Immunity·Kenneth A FrauwirthCraig B Thompson
Dec 4, 2002·Nature Reviews. Immunology·Antonio Lanzavecchia, Federica Sallusto
Feb 24, 1956·Science·O WARBURG
Nov 2, 2004·Nature Reviews. Cancer·Robert A Gatenby, Robert J Gillies
Oct 18, 2005·Molecular and Cellular Biology·Richard V ParryJames L Riley
Jan 27, 2007·Blood·Karin FischerMarina Kreutz
Jan 5, 2008·Annual Review of Immunology·Mary E KeirArlene H Sharpe
Sep 16, 2008·European Journal of Immunology·Candace M ChamThomas F Gajewski
Jun 6, 2009·Current Opinion in Immunology·Ian A Parish, Susan M Kaech
Dec 24, 2009·Cancer Research·Minu K SrivastavaSuzanne Ostrand-Rosenberg
Jun 8, 2010·The New England Journal of Medicine·F Stephen HodiWalter J Urba
Jul 20, 2010·Immunological Reviews·Loise M FranciscoArlene H Sharpe
Dec 30, 2010·Journal of Visualized Experiments : JoVE·David G NichollsDavid A Ferrick
May 11, 2011·The Journal of Clinical Investigation·Lukas BaitschDaniel E Speiser
Jul 9, 2011·Nature Immunology·E John Wherry
Apr 17, 2012·Cell·Mathieu Laplante, David M Sabatini
Jun 5, 2012·The New England Journal of Medicine·Julie R BrahmerJon M Wigginton
Oct 30, 2012·Trends in Immunology·David H Munn, Andrew L Mellor
Jan 10, 2013·Current Opinion in Immunology·Joel CrespoWeiping Zou
May 9, 2013·Annals of the New York Academy of Sciences·Matthew D Vesely, Robert D Schreiber
May 17, 2013·The Journal of Clinical Investigation·Erin E WestRafi Ahmed
Jun 4, 2013·The New England Journal of Medicine·Omid HamidAntoni Ribas
Jun 4, 2013·The New England Journal of Medicine·Jedd D WolchokMario Sznol
Aug 30, 2013·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Yawei LiuShohreh Issazadeh-Navikas
Oct 12, 2013·Science·Erika L PearceRussell G Jones
Nov 6, 2013·Annual Review of Medicine·David B PageJedd D Wolchok
Aug 5, 2014·Nature Immunology·Stanley Ching-Cheng HuangEdward J Pearce
Nov 28, 2014·Nature·Matthew M GubinRobert D Schreiber
Dec 2, 2014·The Journal of Clinical Investigation·Valerie A GerrietsJeffrey C Rathmell
Jan 21, 2015·Trends in Immunology·David O'Sullivan, Erika L Pearce

❮ Previous
Next ❯

Citations

Mar 17, 2016·Mediators of Inflammation·Wen Jing SimJohn Edward Connolly
Jan 19, 2016·Trends in Biochemical Sciences·Maria V Liberti, Jason W Locasale
Jan 20, 2016·Nature Reviews. Immunology·Brian J LaidlawSusan M Kaech
Sep 12, 2015·Cell·Madhusudhanan SukumarNicholas P Restifo
Feb 18, 2016·Journal for Immunotherapy of Cancer·Ping-Chih Ho, Pu-Ste Liu
Dec 10, 2015·Cancer Immunology, Immunotherapy : CII·Laura RaccostaVincenzo Russo
Dec 24, 2015·The Journal of Experimental Medicine·Luke A J O'Neill, Edward J Pearce
May 4, 2016·Oncoimmunology·Wan-Chen Cheng, Ping-Chih Ho
Dec 10, 2015·Nature Medicine·Randy LevinsonBrett Benedetti
Oct 7, 2015·Trends in Immunology·Mary Philip, Andrea Schietinger
Mar 24, 2016·Nature Immunology·Chih-Hao Chang, Erika L Pearce
Mar 31, 2016·Nature Cell Biology·Edward L LaGory, Amato J Giaccia
Sep 25, 2015·Nature Reviews. Cancer·Sarah Seton-Rogers
May 7, 2016·Trends in Immunology·Michael Hölzel, Thomas Tüting
May 6, 2016·Frontiers in Immunology·Jose C Alves-Filho, Eva M Pålsson-McDermott
Mar 2, 2016·Annual Review of Immunology·Susanne H BaumeisterArlene H Sharpe
May 19, 2016·Immunity·Steven R Barthel, Tobias Schatton
May 19, 2016·Immunity·Frank A SchildbergArlene H Sharpe
Apr 14, 2016·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J M PittL Zitvogel
Jun 2, 2016·The Journal of Clinical Investigation·Nadine Assmann, David K Finlay
Jun 14, 2016·The Journal of Clinical Investigation·Asim SahaBruce R Blazar
Jun 28, 2016·Journal of Cancer Research and Clinical Oncology·Marco Johannes BattistaStefan Walenta
May 28, 2016·Antioxidants & Redox Signaling·Géraldine GentricFatima Mechta-Grigoriou
Jul 31, 2016·Chinese Journal of Cancer·Shuang Liu, Yong-Guang Tao
Aug 6, 2016·Nature Reviews. Cancer·Brian J AltmanChi V Dang
Aug 12, 2016·Clinical and Translational Medicine·Christoph HerbelVassiliki A Boussiotis
Aug 17, 2016·Nature Reviews. Immunology·Daniel E SpeiserGrégory Verdeil
Aug 24, 2016·Nature Reviews. Cancer·Raghu Kalluri
Oct 25, 2016·Biochimica Et Biophysica Acta·Chen LiangXianjun Yu
Sep 12, 2016·Trends in Immunology·Nyamdelger SukhbaatarThomas Weichhart
Sep 11, 2016·Biochimica Et Biophysica Acta·Dmitry Namgaladze, Bernhard Brüne

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Cell eTOC

Cell is a scientific journal publishing research across a broad range of disciplines within the life sciences field. Discover the latest research from Cell here.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Cancer Metabolic Reprogramming (Keystone)

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.